SYNVISC
FDA premarket approval P940015/S037 · decided 2016-11-08
Approval details
- PMA number
- P940015
- Supplement
- S037
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SYNVISC
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2016-09-29
- Decision date
- 2016-11-08
- Days to decision
- 40 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- Qualification of Synvisc and Synvisc-One syringe labels from alternate approved suppliers.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.